These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33421649)

  • 1. A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) - Study protocol for a randomised controlled trial.
    Baisley KJ; Whitworth HS; Changalucha J; Pinto L; Dillner J; Kapiga S; de Sanjosé S; Mayaud P; Hayes RJ; Lacey CJ; Watson-Jones D
    Contemp Clin Trials; 2021 Feb; 101():106266. PubMed ID: 33421649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
    Baisley K; Kemp TJ; Kreimer AR; Basu P; Changalucha J; Hildesheim A; Porras C; Whitworth H; Herrero R; Lacey CJ; Schiller JT; Lucas E; Mutani P; Dillner J; Indangasi J; Muwonge R; Hayes RJ; Pinto LA; Watson-Jones D
    Lancet Glob Health; 2022 Oct; 10(10):e1485-e1493. PubMed ID: 36113532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.
    Baisley K; Kemp TJ; Mugo NR; Whitworth H; Onono MA; Njoroge B; Indangasi J; Bukusi EA; Prabhu PR; Mutani P; Galloway DA; Mwanzalime D; Kapiga S; Lacey CJ; Hayes RJ; Changalucha J; Pinto LA; Barnabas RV; Watson-Jones D
    Lancet Glob Health; 2024 Mar; 12(3):e491-e499. PubMed ID: 38365419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
    Watson-Jones D; Changalucha J; Whitworth H; Pinto L; Mutani P; Indangasi J; Kemp T; Hashim R; Kamala B; Wiggins R; Songoro T; Connor N; Mbwanji G; Pavon MA; Lowe B; Mmbando D; Kapiga S; Mayaud P; de SanJosé S; Dillner J; Hayes RJ; Lacey CJ; Baisley K
    Lancet Glob Health; 2022 Oct; 10(10):e1473-e1484. PubMed ID: 36113531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial.
    Barnabas RV; Brown ER; Onono M; Bukusi EA; Njoroge B; Winer RL; Donnell D; Galloway D; Cherne S; Heller K; Leingang H; Morrison S; Rechkina E; McClelland RS; Baeten JM; Celum C; Mugo N;
    Trials; 2021 Sep; 22(1):661. PubMed ID: 34579786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
    Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
    Dobson SR; McNeil S; Dionne M; Dawar M; Ogilvie G; Krajden M; Sauvageau C; Scheifele DW; Kollmann TR; Halperin SA; Langley JM; Bettinger JA; Singer J; Money D; Miller D; Naus M; Marra F; Young E
    JAMA; 2013 May; 309(17):1793-802. PubMed ID: 23632723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.
    Quentin W; Terris-Prestholt F; Changalucha J; Soteli S; Edmunds WJ; Hutubessy R; Ross DA; Kapiga S; Hayes R; Watson-Jones D
    BMC Med; 2012 Nov; 10():137. PubMed ID: 23148516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
    Whitworth H; Changalucha J; Baisley K; Watson-Jones D
    Trop Med Int Health; 2021 Nov; 26(11):1345-1355. PubMed ID: 34310816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
    Porras C; Sampson JN; Herrero R; Gail MH; Cortés B; Hildesheim A; Cyr J; Romero B; Schiller JT; Montero C; Pinto LA; Schussler J; Coronado K; Sierra MS; Kim JJ; Torres CM; Carvajal L; Wagner S; Campos NG; Ocampo R; Kemp TJ; Zuniga M; Lowy DR; Avila C; Chanock S; Castrillo A; Estrada Y; Barrientos G; Monge C; Oconitrillo MY; Kreimer AR
    Vaccine; 2022 Jan; 40(1):76-88. PubMed ID: 34857420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.
    D'Addario M; Redmond S; Scott P; Egli-Gany D; Riveros-Balta AX; Henao Restrepo AM; Low N
    Vaccine; 2017 May; 35(22):2892-2901. PubMed ID: 28455170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
    Iversen OE; Miranda MJ; Ulied A; Soerdal T; Lazarus E; Chokephaibulkit K; Block SL; Skrivanek A; Nur Azurah AG; Fong SM; Dvorak V; Kim KH; Cestero RM; Berkovitch M; Ceyhan M; Ellison MC; Ritter MA; Yuan SS; DiNubile MJ; Saah AJ; Luxembourg A
    JAMA; 2016 Dec; 316(22):2411-2421. PubMed ID: 27893068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania.
    Hsiao A; Struckmann V; Stephani V; Mmbando D; Changalucha J; Baisley K; Levin A; Morgan W; Hutubessy R; Watson-Jones D; Whitworth H; Quentin W
    Vaccine; 2023 Jan; 41(2):372-379. PubMed ID: 36460537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF
    Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
    Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
    Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.
    Sampson JN; Hildesheim A; Herrero R; Gonzalez P; Kreimer AR; Gail MH
    Contemp Clin Trials; 2018 May; 68():35-44. PubMed ID: 29474934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.
    Neuzil KM; Canh DG; Thiem VD; Janmohamed A; Huong VM; Tang Y; Diep NT; Tsu V; LaMontagne DS
    JAMA; 2011 Apr; 305(14):1424-31. PubMed ID: 21486975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania.
    Mitchell KR; Erio T; Whitworth HS; Marwerwe G; Changalucha J; Baisley K; Lacey CJ; Hayes R; de SanJosé S; Watson-Jones D
    Tumour Virus Res; 2021 Dec; 12():200217. PubMed ID: 34051389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.